LONG TERM FOLLOW UP: PHASE I TRIAL OF “BI-SHRNA FURIN/GMCSF DNA/AUTOLOGOUS TUMOR CELL” IMMUNOTHERAPY (FANG™) IN ADVANCED CANCER

Friday, July 26, 2013